BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 205 filers reported holding BRIDGEBIO PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $218,488 | -49.1% | 28,673 | -33.5% | 0.00% | -50.0% |
Q3 2022 | $429,000 | +122.3% | 43,089 | +102.4% | 0.00% | +100.0% |
Q2 2022 | $193,000 | -70.8% | 21,286 | -67.3% | 0.00% | -50.0% |
Q1 2022 | $661,000 | +137.8% | 65,107 | +1330.3% | 0.00% | +100.0% |
Q2 2021 | $278,000 | -92.4% | 4,552 | -92.4% | 0.00% | -93.8% |
Q1 2021 | $3,677,000 | -62.5% | 59,698 | -56.7% | 0.02% | -62.8% |
Q4 2020 | $9,812,000 | +110.9% | 137,985 | +11.3% | 0.04% | +138.9% |
Q3 2020 | $4,653,000 | +21.1% | 124,022 | +5.3% | 0.02% | -5.3% |
Q2 2020 | $3,841,000 | – | 117,785 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |